Carfenazine
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
1-(10-{3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl}-10H-phenothiazin-2-yl)propan-1-one | |
| Clinical data | |
| License data |
|
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number | 2622-30-2 |
| ATC code | none |
| PubChem | CID 18104 |
| IUPHAR/BPS | 7140 |
| DrugBank | DB01038 |
| ChemSpider | 17100 |
| UNII | CLY16Y8Z7E |
| ChEMBL | CHEMBL1201328 |
| Synonyms | Proketazine, Carphenazin |
| Chemical data | |
| Formula | C24H31N3O2S |
| Molar mass | 425.6 g/mol |
| |
| |
Carfenazine (INN), used in the form of carphenazine maleate (USAN), is an antipsychotic agent,[1] mainly used for the treatment of chronic schizophrenia.[2]
References
- ↑ Tislow, Richard (1961). "Pharmacology and toxicity of carphenazine". Diseases of Nervous System 22 (Suppl. No. 2): 7–13.
- ↑ Carphenazine, DrugBank
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
